THRALENT Trademark

Trademark Overview

On Tuesday, November 11, 2014, a trademark application was filed for THRALENT with the United States Patent and Trademark Office. The USPTO has given the THRALENT trademark a serial number of 86451145. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 16, 2018. This trademark is owned by Glaxo Group Limited. The THRALENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
thralent

General Information

Serial Number86451145
Word MarkTHRALENT
Filing DateTuesday, November 11, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 16, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 14, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 19, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, July 16, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 16, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, November 18, 2017EXTENSION 5 GRANTED
Saturday, November 4, 2017EXTENSION 5 FILED
Saturday, November 4, 2017TEAS EXTENSION RECEIVED
Thursday, June 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 6, 2017EXTENSION 4 GRANTED
Tuesday, June 6, 2017EXTENSION 4 FILED
Tuesday, June 6, 2017TEAS EXTENSION RECEIVED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 14, 2016EXTENSION 3 GRANTED
Thursday, December 1, 2016EXTENSION 3 FILED
Thursday, December 1, 2016TEAS EXTENSION RECEIVED
Tuesday, July 5, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, July 3, 2016EXTENSION 2 GRANTED
Tuesday, May 31, 2016EXTENSION 2 FILED
Friday, July 1, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 31, 2016TEAS EXTENSION RECEIVED
Saturday, November 21, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 19, 2015EXTENSION 1 GRANTED
Thursday, November 19, 2015EXTENSION 1 FILED
Thursday, November 19, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 9, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 14, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 14, 2015PUBLISHED FOR OPPOSITION
Wednesday, March 25, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 3, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 3, 2015ASSIGNED TO EXAMINER
Wednesday, November 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 14, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

thralent pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological